全文获取类型
收费全文 | 137935篇 |
免费 | 12230篇 |
国内免费 | 7471篇 |
学科分类
医药卫生 | 157636篇 |
出版年
2024年 | 96篇 |
2023年 | 1233篇 |
2022年 | 2084篇 |
2021年 | 4308篇 |
2020年 | 3718篇 |
2019年 | 3361篇 |
2018年 | 3622篇 |
2017年 | 3635篇 |
2016年 | 3626篇 |
2015年 | 5654篇 |
2014年 | 7331篇 |
2013年 | 7848篇 |
2012年 | 11353篇 |
2011年 | 12032篇 |
2010年 | 9040篇 |
2009年 | 7631篇 |
2008年 | 9218篇 |
2007年 | 9114篇 |
2006年 | 8618篇 |
2005年 | 7832篇 |
2004年 | 6083篇 |
2003年 | 6140篇 |
2002年 | 4910篇 |
2001年 | 3959篇 |
2000年 | 3200篇 |
1999年 | 2310篇 |
1998年 | 1271篇 |
1997年 | 1284篇 |
1996年 | 925篇 |
1995年 | 835篇 |
1994年 | 722篇 |
1993年 | 497篇 |
1992年 | 663篇 |
1991年 | 571篇 |
1990年 | 470篇 |
1989年 | 375篇 |
1988年 | 364篇 |
1987年 | 305篇 |
1986年 | 238篇 |
1985年 | 236篇 |
1984年 | 153篇 |
1983年 | 96篇 |
1982年 | 63篇 |
1981年 | 64篇 |
1980年 | 40篇 |
1979年 | 68篇 |
1978年 | 58篇 |
1976年 | 40篇 |
1973年 | 51篇 |
1970年 | 37篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
Proteomic Profiling of Small Extracellular Vesicles Isolated from the Plasma of Vietnamese Patients with Non-Small Cell Lung Cancer Reveals Some Potential Biomarkers 下载免费PDF全文
Thao Phuong Bui Phuong Lan LeLinh Thi Tu Nguyen Le Trung ThoThai Hong Trinh 《Asian Pacific journal of cancer prevention》2022,23(6):1893-1900
Background: Considering the poor prognosis of non-small cell lung cancer (NSCLC), the objective of this study was to examine the potential of plasma-derived vesicles as a source of lung cancer-specific proteins. Extracellular vesicle (EV) cargos are specific to the source cells, hence they have the potential of being a source of cancer-specific proteins. Methods: The proteins differently expressed in cancer were determined and derived from EVs isolated from the plasma of NSCLC patients at the National Lung Hospital. To this end, purification was done using gel filtration chromatography and ultracentrifugation. In addition, nano liquid chromatography mass spectrometry (LC–MS/MS) was used for analyzing. Results: Fifty-seven EV-derived proteins related to NSCLC were highlighted in this research. Some of them have not been addressed before, such as EEF1A1 (elongation factor 1-α1), KPNB1 (Importin subunit beta 1), SRC (proto-oncogene tyrosine-protein kinase) and ACTC1 (actin, alpha cardiac muscle 1). This list was further confirmed through a comparison with ExoCarta and Vesiclepedia. Conclusion: This study is the first work to show the involvement of several novel proteins of small EV (EEF1A1, KPNB1, SRC, and ACTC1) in the progression of NSCLC. The results suggested that they could serve as novel biomarkers for non-small cell lung cancer in the future. 相似文献
5.
兰展仇洪冯磊黄章峰禤义张传东盘丽华 《中国临床神经外科杂志》2022,27(2):107-109
目的 探讨人胶质母细胞瘤(GBM)组织微小核糖核酸-4516(miR-4516)的表达情况及其与病人预后的关系。方法选取 2015年 1月~2019年 5月手术切除的 GBM组织 89例和颅脑损伤内减压术切除的非肿瘤脑组织 35例为对照组,采用 qRT-PCR检测 miR-4516的表达水平,根据 miR-4516表达水平的中位数分为高表达和低表达。GBM病人术后随访 2年,记录生存情况。结果 GBM组织 miR-4516表达水平([ 5.32±1.75)]明显高于对照组([ 1.13±0.45);P<0.01]。术后 2年随访,42例(47.19%)生存,47例 47(52.81%)死亡。多因素 Cox回归分析显示,miR-4516高表达是 GBM生存预后病例的独立危险因素(P<0.05)。生存曲线分析显示 miR-4516高表达组 2年累积生存率(27.45%)明显低于低表达组(73.68%;P<0.001)。结论 GBM组织 miR-4516表达增高,其高表达是病人预后不良的危险因素。 相似文献
6.
目的 评价多功能套针浮刺疗法对神经根型颈椎病的临床疗效。方法 选取256例神经根型颈椎病患者,按随机数字表法分为观察组与对照组各128例。观察组应用多功能套针浮刺疗法进行干预,对照组为常规针刺治疗。两组患者均治疗7天。分别于治疗前后观察两组患者的简化McGill疼痛问卷(SF-MPQ)、国际标准颈椎功能障碍指数(NDI)和田中靖久颈椎病症状20分法量表评分,并于治疗结束后3个月观察复发率。结果 两组患者治疗后的SF-MPQ量表评分、NDI量表评分及田中靖久颈椎病症状20分法评分与治疗前相比均有改善(P<0.05),且观察组优于对照组(P<0.05);两组患者于治疗后3个月随访,SF-MPQ量表评分与治疗后相比均有改善,且观察组优于对照组(P<0.05);观察组临床疗效总有效率为96.88%,愈显率为81.25%;对照组总有效率为78.13%,愈显率为46.88%,观察组优于对照组(P<0.05)。结论 应用多功能套针浮刺疗法治疗神经根型颈椎病临床疗效显著,见效较快,可有效降低其复发率,且作用稳定,效果持久,值得临床推广应用。 相似文献
7.
Su Chien-Chia Lee Yi-Chieh Lee Peter Richmond Candano 《Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie》2022,260(7):2397-2397
Graefe's Archive for Clinical and Experimental Ophthalmology - 相似文献
8.
9.
10.
Kyung-Suk Suh Suk Kyun Hong Sola Lee Su young Hong Sanggyun Suh Eui Soo Han Seong-Mi Yang YoungRok Choi Nam-Joon Yi Kwang-Woong Lee 《American journal of transplantation》2022,22(1):260-265
Minimally invasive approaches are increasingly being applied in surgeries and have recently been used in living donor hepatectomy. We have developed a safe and reproducible method for minimally invasive living donor liver transplantation, which consists of pure laparoscopic explant hepatectomy and pure laparoscopic implantation of the graft, which was inserted through a suprapubic incision. Pure laparoscopic explant hepatectomy without liver fragmentation was performed in a 60-year-old man with alcoholic liver cirrhosis and hepatocellular carcinoma. The explanted liver was retrieved through a suprapubic incision. A modified right liver graft, procured from his 24-year-old son using the pure laparoscopic method, was inserted through a suprapubic incision, and implantation was performed intracorporeally throughout the procedure. The time required to remove the liver was 369 min, and the total operative time was 960 min. No complications occurred during or after the surgery. The patient recovered well, and his hospital stay was of 11 days. Pure laparoscopic living donor liver transplantation from explant hepatectomy to implantation was performed successfully. It is a feasible procedure when performed by a highly experienced surgeon and transplantation team. Further studies with larger sample sizes are needed to confirm its safety and feasibility.